Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.

Zannad, F; Stough, WG; Lipicky, RJ; Tamargo, J; Bakris, GL; Borer, JS; Alonso García, ML; Hadjadj, S; Koenig, W; Kupfer, S; +9 more... McCullough, PA; Mosenzon, O; Pocock, S; Scheen, AJ; Sourij, H; Van der Schueren, B; Stahre, C; White, WB; Calvo, G; (2016) Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion. European heart journal Cardiovascular pharmacotherapy, 2 (3). pp. 200-205. ISSN 2055-6837 DOI: https://doi.org/10.1093/ehjcvp/pvw007

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/ehjcvp/pvw007

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar